Ann: Trading Halt, page-174

Zoono has had early mover advantage, they went and took market share when there was fear in the air about Covid-19. Their stars were all aligned.
The test results were the first step for them that allowed more deals to flow through.

Very important for SKN to have their tests come back positive too. What is equally important is managements ability to create lucrative deals that has longevity and have the ability to actually execute them.
If we want to see our MC anywhere near ZNO then we need sales to back it.
Personally I would give SKN a better valuation metrics over ZNO if our sales were equal based on the fact that SKN products are more and better diversified